- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ObamaCare, Doctor Shortage To Spur $2 Billion Telehealth Market
The business of treating patients via telehealth in the U.S. will dramatically increase to nearly $2 billion in revenue within five years due to a confluence of events in the health care industry from doctor shortages to provider payment changes under the Affordable Care Act.
The business of treating patients via telehealth in the U.S. will dramatically increase to nearly $2 billion in revenue within five years due to a confluence of events in the health care industry from doctor shortages to provider payment changes under the Affordable Care Act.
A new report from information and analytics firm IHS says revenue expansion of the teleheath space — which allows doctors and other providers to monitor patients remotely via various devices, computers and related digital technology — will grow to $1.9 billion in 2018 in the U.S. from $240 million this year.
The trend toward telehealth will be driven by employers, private insurers and the Affordable Care Act, which makes doctors and hospitals more accountable by moving medical care providers away from fee-for-service medicine where they are paid based on volume of services to reimbursement based on the value of care they provide. This trend often uses doctors as a quarterback of sorts in concert with nurses and other allied health professionals to keep patients out of the hospital where care is more expensive.
Read the full story here: http://onforb.es/18IjsZv
Source: Forbes
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
PAH Treatment Benefits Extend to Patients With Repaired Congenital Heart Disease
March 14th 2025Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ranges from 4% to 28%, according to studies from the US and Europe—and that the prevalence of these comorbid condition is on the rise.
Read More
